February 8, 2021 | HealthClot

Orion and Bayer expand development program for darolutamide in prostate cancer

By HealthClot Moderator
February 8, 2021
0

Orion and Bayer expand development program for darolutamide in prostate cancer ORION CORPORATION PRESS RELEASE 8 FEBRUARY 2021 at 14.00 EET Orion and Bayer expand development program for darolutamide in prostate cancer Phase III study ARANOTE to be initiated in metastatic hormone-sensitive prostate cancer (mHSPC) assessing the novel androgen-receptor antagonist in combination with standard […]

Hologic taps Google Cloud for AI-driven cervical cancer screening collaboration

By HealthClot Moderator
February 8, 2021
0

Hologic taps Google Cloud for AI-driven cervical cancer screening collaboration Hologic has tapped Google Cloud to help elevate its digital pathology platforms for diagnosing cervical cancer with new artificial intelligence and machine learning programs. The medtech’s Genius cytology system digitally stacks 2D images of a patient’s cells to provide additional visual depth to glass Pap […]

Mapping challenges India faces in fight against cancer

By HealthClot Moderator
February 8, 2021
0

Mapping challenges India faces in fight against cancer Despite advancements in medical technology and health infrastructure, the cancer graph in India continues to climb calling for a need to relook and upscale the strategies for prevention and control of the disease. Cancer arises from the transformation of normal cells into tumour cells in a multistage […]

Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the …

By HealthClot Moderator
February 8, 2021
0

Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the … Corresponding Author Multiple Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Correspondence: Dickran Kazandjian, M.D., Multiple Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, […]